Metabolic Shifts in Immunity and Inflammation

Sites of ongoing inflammation and triggered immune responses are characterized by significant changes in metabolic activity. Recent studies have indicated that such shifts in tissue metabolism result from a combination of profound recruitment of inflammatory cells (neutrophils and monocytes) and high proliferation rates among lymphocyte populations. The resultant shifts in energy supply and demand can result in metabolic acidosis and diminished delivery and/or availability of oxygen, leading to hypoxia extensive enough to trigger transcriptional and translation changes in tissue phenotype. Such phenotypic shifts can imprint fundamental changes to tissue metabolism. In this study, we review recent work addressing metabolic changes and metabolic control of inflammation and immunity.

[1]  L. Obeid,et al.  Sphingosine Kinase 1 Is Up-regulated during Hypoxia in U87MG Glioma Cells ROLE OF HYPOXIA-INDUCIBLE FACTORS 1 AND 2 * , 2020 .

[2]  S. Offenbacher,et al.  Alteration of PTGS2 Promoter Methylation in Chronic Periodontitis , 2010, Journal of dental research.

[3]  J. Penn,et al.  Role of cytosolic phospholipase A(2) in retinal neovascularization. , 2010, Investigative ophthalmology & visual science.

[4]  W. Hörl,et al.  The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  M. Perretti,et al.  Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.

[6]  S. Colgan,et al.  Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation , 2009, Expert opinion on therapeutic targets.

[7]  J. O’Sullivan,et al.  Generation of an epigenetic signature by chronic hypoxia in prostate cells. , 2009, Human molecular genetics.

[8]  V. Nizet,et al.  Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.

[9]  Greg M. Delgoffe,et al.  mTOR: taking cues from the immune microenvironment , 2009, Immunology.

[10]  J. Karliner,et al.  Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. , 2009, American journal of physiology. Heart and circulatory physiology.

[11]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[12]  S. Colgan,et al.  Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis 1 , 2009, The Journal of Immunology.

[13]  G. Semenza,et al.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1. , 2009, Physiology.

[14]  Wei Li,et al.  Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis , 2009, Proceedings of the National Academy of Sciences.

[15]  Jie Zhou,et al.  Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells , 2009, Molecular Cancer Research.

[16]  C. Serhan,et al.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.

[17]  Jens Vilstrup Johansen,et al.  The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF* , 2008, Journal of Biological Chemistry.

[18]  P. Ratcliffe,et al.  Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. , 2008, The Biochemical journal.

[19]  Dan Yang,et al.  A2B adenosine receptor gene deletion attenuates murine colitis. , 2008, Gastroenterology.

[20]  K. Seeger,et al.  Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. , 2008, Biochemical and biophysical research communications.

[21]  K. Morimura,et al.  Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. , 2008, Gastroenterology.

[22]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[23]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[24]  T. Kuijpers,et al.  Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex Organisation , 2008, PloS one.

[25]  S. Colgan,et al.  Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition , 2008 .

[26]  E. Cummins,et al.  The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. , 2008, Gastroenterology.

[27]  T. Veenstra,et al.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.

[28]  C. Taylor,et al.  Hypoxia and gastrointestinal disease , 2007, Journal of Molecular Medicine.

[29]  S. Gay,et al.  Epigenetics in inflammatory rheumatic diseases. , 2007, Arthritis and rheumatism.

[30]  G. Natoli,et al.  The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.

[31]  I. Filimonov,et al.  Molecular oxygen (a substrate of the cyclooxygenase reaction) in the kinetic mechanism of the bifunctional enzyme prostaglandin-H-synthase , 2007, Biochemistry (Moscow).

[32]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.

[33]  L. Sowers,et al.  Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. , 2007, Cancer research.

[34]  Brian R. Lawson,et al.  Inhibition of Transmethylation Down-Regulates CD4 T Cell Activation and Curtails Development of Autoimmunity in a Model System , 2007, The Journal of Immunology.

[35]  P. Ratcliffe.  HIF-1 and HIF-2: working alone or together in hypoxia? , 2007, The Journal of clinical investigation.

[36]  G. Burnstock,et al.  Purine and pyrimidine receptors , 2007, Cellular and Molecular Life Sciences.

[37]  Xuexian O Yang,et al.  Chromatin Remodeling of Interleukin-17 (IL-17)-IL-17F Cytokine Gene Locus during Inflammatory Helper T Cell Differentiation* , 2007, Journal of Biological Chemistry.

[38]  S. Colgan,et al.  Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. , 2007, The Journal of clinical investigation.

[39]  Anjana Rao,et al.  Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells , 2007, Nature Immunology.

[40]  Edgar Schmitt,et al.  Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.

[41]  Courtney M. Lappas,et al.  Cutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis1 , 2006, The Journal of Immunology.

[42]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[43]  司履生.  Cancer epigenetics , 2006 .

[44]  Danny Reinberg,et al.  Histone Lysine Demethylases and Their Impact on Epigenetics , 2006, Cell.

[45]  Bogdan Tanasa,et al.  Regulation of Th2 differentiation and Il4 locus accessibility. , 2006, Annual review of immunology.

[46]  S. Colgan,et al.  Physiological roles for ecto-5’-nucleotidase (CD73) , 2006, Purinergic Signalling.

[47]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[48]  T. Spector,et al.  Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Jian-Ping Zuo,et al.  Inhibition of S-Adenosyl-l-homocysteine Hydrolase Induces Immunosuppression , 2005, Journal of Pharmacology and Experimental Therapeutics.

[50]  W. Reik,et al.  Epigenetic reprogramming in mammals. , 2005, Human molecular genetics.

[51]  M. Sitkovsky,et al.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. , 2005, Nature reviews. Immunology.

[52]  P. Laird.  Cancer epigenetics. , 2005, Human molecular genetics.

[53]  John E Tomaszewski,et al.  Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. , 2004, The Journal of clinical investigation.

[54]  C. Shelley,et al.  Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[56]  R. Bruick,et al.  Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. , 2003, Genes & development.

[57]  P. Ratcliffe,et al.  2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. , 2003, Bioorganic & medicinal chemistry letters.

[58]  P. Ratcliffe,et al.  HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels , 2003, Journal of Cell Science.

[59]  N. Abraham,et al.  COX-2 lack of function in hypoxia-induced ocular surface inflammation. , 2003, Thrombosis research.

[60]  P. Ratcliffe,et al.  Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. , 2003, Bioorganic & medicinal chemistry letters.

[61]  S. Reddy,et al.  Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  L. Poellinger,et al.  Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells , 2003 .

[63]  S. Reddy,et al.  Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Pollard,et al.  Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.

[65]  F. Lembeck,et al.  Severe Hypoxia Inhibits Prostaglandin I2 Biosynthesis and Vasodilatory Responses Induced by Ionophore A23187 in the Isolated Rabbit Ear , 2002, Pharmacology.

[66]  R. Bolli,et al.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. , 2002, Cardiovascular research.

[67]  C. Thompson,et al.  Homeostatic control of lymphocyte survival: potential origins and implications , 2002, Nature Immunology.

[68]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[69]  David I Stuart,et al.  Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. , 2002, Nature.

[70]  P. Buttrick,et al.  Inhibition of Collagen Synthesis With Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation After Myocardial Infarction , 2001, Circulation.

[71]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[72]  G. Semenza,et al.  HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus , 2001, Cell.

[73]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[74]  M. Murakami,et al.  Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2 * , 2001, The Journal of Biological Chemistry.

[75]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[76]  D. Jacobsen,et al.  Homocysteine in health and disease , 2001 .

[77]  E. Conner,et al.  S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. , 2001, The Journal of pharmacology and experimental therapeutics.

[78]  C. Clish,et al.  Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.

[79]  L. Poellinger,et al.  Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.

[80]  A. Harris,et al.  Macrophage responses to hypoxia: relevance to disease mechanisms , 1999, Journal of leukocyte biology.

[81]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[82]  S. Yamamoto,et al.  Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate. , 1999, Biochimica et biophysica acta.

[83]  P. Chiang.  Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. , 1998, Pharmacology & therapeutics.

[84]  L. Wartman,et al.  Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. , 1998, Gene expression.

[85]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[86]  Y Fujii-Kuriyama,et al.  A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[87]  V. Sexl,et al.  Stimulation of the Mitogen-activated Protein Kinase via the A2A-Adenosine Receptor in Primary Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[88]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[89]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[90]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Guppy,et al.  Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. , 1994, The Journal of biological chemistry.

[92]  G. Babcock,et al.  Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. , 1993, Cellular immunology.

[93]  J. Remacle,et al.  Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. , 1993, The American journal of physiology.

[94]  R. Baldessarini.  Neuropharmacology of S-adenosyl-L-methionine. , 1987, The American journal of medicine.

[95]  I. Marks,et al.  Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer. , 1987, The American journal of medicine.

[96]  T. Herlin,et al.  Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.

[97]  B. Babior,et al.  Effects of oxygen tension and pH on the respiratory burst of human neutrophils. , 1979, Blood.